<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Peacock E</submitter><funding>NCATS NIH HHS</funding><funding>NICHD NIH HHS</funding><funding>NIA NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>153-161</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7752228</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>39(1)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>The aim of this study was to determine the association of low antihypertensive medication adherence with decline in health-related quality of life (HRQOL) over 1 year.&lt;h4>Methods&lt;/h4>We used data from older men and women with hypertension (n = 1525) enrolled in the Cohort Study of Medication Adherence among Older Adults. Adherence was measured using the validated self-report four-item Krousel-Wood Medication Adherence Scale (K-Wood-MAS-4) (low adherence = score ≥1) and prescription refill-based proportion of days covered (PDC) (low adherence = PDC &lt; 0.80). We defined decline in HRQOL as a decrease in Mental Component Summary (MCS) or Physical Component Summary (PCS) score (from the RAND 36-Item Health Survey 1.0 administered at two time points - at the time of adherence assessment and 1 year later) equivalent to the minimal important difference (MID) for each respective summary score, calculated as the average of MID estimates derived from distribution and anchor-based approaches.&lt;h4>Results&lt;/h4>The prevalence of low adherence was 38.6% using the K-Wood-MAS-4 and 23.9% using PDC. On the basis of mean MID estimates of 4.40 for MCS and 5.16 for PCS, 21.8 and 25.2% of participants experienced a decline in MCS and PCS, respectively, over 1 year. Low adherence was associated with a decline in MCS for K-Wood-MAS-4 [prevalence ratio = 1.32, 95% confidence interval (95% CI) 1.08-1.62, P = 0.008], but not PDC (prevalence ratio  = 1.17, 95% CI 0.94-1.47, P = 0.168). Low adherence was not associated with decline in PCS (K-Wood-MAS-4: prevalence ratio  = 0.95, 95% CI 0.79-1.16; PDC: prevalence ratio  = 1.10, 95% CI 0.90-1.35).&lt;h4>Conclusion&lt;/h4>Low self-report medication adherence is associated with decline in mental HRQOL over 1 year in older adults with hypertension.</pubmed_abstract><journal>Journal of hypertension</journal><pubmed_title>Low medication adherence is associated with decline in health-related quality of life: results of a longitudinal analysis among older women and men with hypertension.</pubmed_title><pmcid>PMC7752228</pmcid><funding_grant_id>P20 GM109036</funding_grant_id><funding_grant_id>K12 HD043451</funding_grant_id><funding_grant_id>R01 AG022536</funding_grant_id><funding_grant_id>U54 GM104940</funding_grant_id><funding_grant_id>R01 HL133790</funding_grant_id><funding_grant_id>R01 HL130500</funding_grant_id><funding_grant_id>UL1 TR001417</funding_grant_id><pubmed_authors>Krousel-Wood M</pubmed_authors><pubmed_authors>Muntner P</pubmed_authors><pubmed_authors>Holt EW</pubmed_authors><pubmed_authors>Lenane Z</pubmed_authors><pubmed_authors>Peacock E</pubmed_authors><pubmed_authors>Craig LS</pubmed_authors><pubmed_authors>Joyce C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Low medication adherence is associated with decline in health-related quality of life: results of a longitudinal analysis among older women and men with hypertension.</name><description>&lt;h4>Objective&lt;/h4>The aim of this study was to determine the association of low antihypertensive medication adherence with decline in health-related quality of life (HRQOL) over 1 year.&lt;h4>Methods&lt;/h4>We used data from older men and women with hypertension (n = 1525) enrolled in the Cohort Study of Medication Adherence among Older Adults. Adherence was measured using the validated self-report four-item Krousel-Wood Medication Adherence Scale (K-Wood-MAS-4) (low adherence = score ≥1) and prescription refill-based proportion of days covered (PDC) (low adherence = PDC &lt; 0.80). We defined decline in HRQOL as a decrease in Mental Component Summary (MCS) or Physical Component Summary (PCS) score (from the RAND 36-Item Health Survey 1.0 administered at two time points - at the time of adherence assessment and 1 year later) equivalent to the minimal important difference (MID) for each respective summary score, calculated as the average of MID estimates derived from distribution and anchor-based approaches.&lt;h4>Results&lt;/h4>The prevalence of low adherence was 38.6% using the K-Wood-MAS-4 and 23.9% using PDC. On the basis of mean MID estimates of 4.40 for MCS and 5.16 for PCS, 21.8 and 25.2% of participants experienced a decline in MCS and PCS, respectively, over 1 year. Low adherence was associated with a decline in MCS for K-Wood-MAS-4 [prevalence ratio = 1.32, 95% confidence interval (95% CI) 1.08-1.62, P = 0.008], but not PDC (prevalence ratio  = 1.17, 95% CI 0.94-1.47, P = 0.168). Low adherence was not associated with decline in PCS (K-Wood-MAS-4: prevalence ratio  = 0.95, 95% CI 0.79-1.16; PDC: prevalence ratio  = 1.10, 95% CI 0.90-1.35).&lt;h4>Conclusion&lt;/h4>Low self-report medication adherence is associated with decline in mental HRQOL over 1 year in older adults with hypertension.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2024-02-15T21:04:49.059Z</modification><creation>2021-02-20T15:06:00Z</creation></dates><accession>S-EPMC7752228</accession><cross_references><pubmed>32675745</pubmed><doi>10.1097/HJH.0000000000002590</doi></cross_references></HashMap>